
Tyrosine kinase inhibitors in head and neck squamous cell carcinoma – a therapeutic chance?
Author(s) -
Anne Lammert,
Annette Affolter,
J Heid,
Y Jakob,
Frederic Jungbauer,
Simone A. Ludwig,
Nicole Rotter,
Claudia Scherl,
E Tenschert,
Jeffrey A. Kern
Publication year - 2021
Publication title -
laryngo-, rhino-, otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0041-1727986
Subject(s) - cetuximab , head and neck squamous cell carcinoma , tyrosine kinase , cancer research , epidermal growth factor receptor , medicine , receptor tyrosine kinase , growth factor receptor , egfr inhibitors , oncology , head and neck cancer , receptor , cancer , colorectal cancer